386 related articles for article (PubMed ID: 28322972)
1. Potential role of CYP1B1 in the development and treatment of metabolic diseases.
Li F; Zhu W; Gonzalez FJ
Pharmacol Ther; 2017 Oct; 178():18-30. PubMed ID: 28322972
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasis.
Larsen MC; Bushkofsky JR; Gorman T; Adhami V; Mukhtar H; Wang S; Reeder SB; Sheibani N; Jefcoate CR
Arch Biochem Biophys; 2015 Apr; 571():21-39. PubMed ID: 25703193
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of cytochrome P450 (CYP) 1B1.
Dutour R; Poirier D
Eur J Med Chem; 2017 Jul; 135():296-306. PubMed ID: 28458135
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1 family and cancers.
Go RE; Hwang KA; Choi KC
J Steroid Biochem Mol Biol; 2015 Mar; 147():24-30. PubMed ID: 25448748
[TBL] [Abstract][Full Text] [Related]
5. Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4α and PPARα.
Bushkofsky JR; Maguire M; Larsen MC; Fong YH; Jefcoate CR
Arch Biochem Biophys; 2016 May; 597():30-47. PubMed ID: 27036855
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 1B1 Expression Regulates Intracellular Iron Levels and Oxidative Stress in the Retinal Endothelium.
Song YS; Zaitoun IS; Wang S; Darjatmoko SR; Sorenson CM; Sheibani N
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768740
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009.
Shimada T; Oda Y; Gillam EM; Guengerich FP; Inoue K
Drug Metab Dispos; 2001 Sep; 29(9):1176-82. PubMed ID: 11502724
[TBL] [Abstract][Full Text] [Related]
8. Identification of 19-(
Shoieb SM; El-Sherbeni AA; El-Kadi AOS
Drug Metab Dispos; 2019 Feb; 47(2):67-70. PubMed ID: 30420405
[TBL] [Abstract][Full Text] [Related]
9. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
D'Uva G; Baci D; Albini A; Noonan DM
Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
Ziegler N; Awwad K; Fisslthaler B; Reis M; Devraj K; Corada M; Minardi SP; Dejana E; Plate KH; Fleming I; Liebner S
J Neurosci; 2016 Aug; 36(34):8921-35. PubMed ID: 27559173
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation.
Zhou L; Chen W; Cao C; Shi Y; Ye W; Hu J; Wang L; Zhou W
Eur J Med Chem; 2020 Mar; 189():112028. PubMed ID: 31945665
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.
Chang I; Mitsui Y; Kim SK; Sun JS; Jeon HS; Kang JY; Kang NJ; Fukuhara S; Gill A; Shahryari V; Tabatabai ZL; Greene KL; Dahiya R; Shin DM; Tanaka Y
Oncotarget; 2017 Jun; 8(24):39087-39100. PubMed ID: 28388569
[TBL] [Abstract][Full Text] [Related]
13. The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.
Maayah ZH; Althurwi HN; El-Sherbeni AA; Abdelhamid G; Siraki AG; El-Kadi AO
Mol Cell Biochem; 2017 May; 429(1-2):151-165. PubMed ID: 28251434
[TBL] [Abstract][Full Text] [Related]
14. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 1b1 in polycyclic aromatic hydrocarbon (PAH)-induced skin carcinogenesis: Tumorigenicity of individual PAHs and coal-tar extract, DNA adduction and expression of select genes in the Cyp1b1 knockout mouse.
Siddens LK; Bunde KL; Harper TA; McQuistan TJ; Löhr CV; Bramer LM; Waters KM; Tilton SC; Krueger SK; Williams DE; Baird WM
Toxicol Appl Pharmacol; 2015 Sep; 287(2):149-160. PubMed ID: 26049101
[TBL] [Abstract][Full Text] [Related]
16. Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene.
Chun YJ; Lee SK; Kim MY
Drug Metab Dispos; 2005 Dec; 33(12):1771-6. PubMed ID: 16120791
[TBL] [Abstract][Full Text] [Related]
17. Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity.
Li F; Jiang C; Larsen MC; Bushkofsky J; Krausz KW; Wang T; Jefcoate CR; Gonzalez FJ
J Proteome Res; 2014 May; 13(5):2679-87. PubMed ID: 24684199
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 1B1: A Key Regulator of Ocular Iron Homeostasis and Oxidative Stress.
Song YS; Annalora AJ; Marcus CB; Jefcoate CR; Sorenson CM; Sheibani N
Cells; 2022 Sep; 11(19):. PubMed ID: 36230892
[TBL] [Abstract][Full Text] [Related]
19. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues.
Muskhelishvili L; Thompson PA; Kusewitt DF; Wang C; Kadlubar FF
J Histochem Cytochem; 2001 Feb; 49(2):229-36. PubMed ID: 11156691
[TBL] [Abstract][Full Text] [Related]
20. Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.
Cui J; Meng Q; Zhang X; Cui Q; Zhou W; Li S
J Med Chem; 2015 Apr; 58(8):3534-47. PubMed ID: 25799264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
